Sign In

Daniel Lynch

Executive Venture Partner @GVteam

Daniel Lynch is an accomplished professional with a diverse educational background and extensive experience in leadership roles within the biotechnology and pharmaceutical industries.

He pursued his education at prestigious institutions, including Phillips Academy, Wesleyan University where he earned a Bachelor of Arts (B.A.) in Mathematics, and the Darden Business School where he obtained his MBA.

Daniel Lynch has held prominent positions in various organizations, serving as Chairman of the Board at Xilio, SpringWorks, bluebird, Blueprint, and Translate, while previously leading Xilio Therapeutics, SpringWorks Therapeutics, Blueprint Medicines, Translate Bio, bluebirdbio, Surface Oncology Inc., Nimbus Discovery, BIND Therapeutics, Ember Therapeutics, Avila Therapeutics, Stromedix Inc., and ImClone Systems.

His extensive experience also includes finance roles at Bristol-Myers Squibb, demonstrating his versatility in both leadership and financial domains.

With his wealth of experience and background in mathematics and business, Daniel Lynch continues to be a significant figure in the biotechnology and pharmaceutical sectors.

Daniel Lynch
Add to my network

Location

Boston, Massachusetts, United States